Your session is about to expire
← Back to Search
Ban & Tailored Pamphlet & Intervention for Smoking (AFV Trial)
N/A
Waitlist Available
Led By Gerald W. Talcott, Ph.D.
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month follow-up
Awards & highlights
AFV Trial Summary
The prevalence of tobacco use in the military is too high. This study is designed to take advantage of the 8.5 weeks of forced tobacco cessation during Basic Military Training and develop effective interventions to prevent tobacco relapse. Hypotheses or Research Questions: Are there differences in the rate of relapse between three groups participating in a tobacco abstinence maintenance intervention? Do the tobacco abstinence maintenance interventions delay relapse?
Eligible Conditions
- Smoking
- Smoking Cessation
AFV Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Smoking cessation maintenance
Secondary outcome measures
Delayed relapse among those who relapse to tobacco use
AFV Trial Design
3Treatment groups
Experimental Treatment
Group I: Ban & Tailored Pamphlet & InterventionExperimental Treatment3 Interventions
After 8.5 weeks of tobacco use cessation during Basic Military Training subjects are provided a tailored relapse prevention pamphlet inspired by Forever Free and tailored for use in the United States Air Force. In addition they are given a face to face relapse prevention intervention.
Group II: Ban & Tailored PamphletExperimental Treatment2 Interventions
After 8.5 weeks of tobacco use cessation during Basic Military Training subjects are provided a tailored relapse prevention pamphlet inspired by Forever Free and tailored for use in the United States Air Force
Group III: Ban & Informational PamphletExperimental Treatment2 Interventions
Following 8.5 weeks of cessation subjects are given an informational pamphlet on tobacco cessation and relapse prevention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Informational Pamphlet
2019
N/A
~170
Find a Location
Who is running the clinical trial?
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,841 Previous Clinical Trials
47,791,105 Total Patients Enrolled
21 Trials studying Smoking
19,767 Patients Enrolled for Smoking
United States Air ForceFED
18 Previous Clinical Trials
28,971 Total Patients Enrolled
University of MinnesotaOTHER
1,381 Previous Clinical Trials
1,528,284 Total Patients Enrolled
10 Trials studying Smoking
5,288 Patients Enrolled for Smoking
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger